Engineering customized nanovaccines for enhanced cancer immunotherapy  被引量:1

在线阅读下载全文

作  者:Jinyu Guo Changhua Liu Zhaoyang Qi Ting Qiu Jin Zhang Huanghao Yang 

机构地区:[1]Qingyuan Innovation Laboratory,1 Xueyuan Road,Quanzhou,362801,PR China [2]College of Chemical Engineering,Fuzhou University,2 Xueyuan Road,Fuzhou,350108,PR China [3]MOE Key Laboratory for Analytical Science of Food Safety and Biology,State Key Laboratory of Photocatalysis on Energy and Environment,College of Chemistry,Fuzhou University,2 Xueyuan Road,Fuzhou,350108,PR China

出  处:《Bioactive Materials》2024年第6期330-357,共28页生物活性材料(英文)

基  金:financially supported by the National Key R&D Program of China(Grant No.2022YFB3808000/2022YFB3808001,Grant No.2021YFC2400600/2021 YFC2400604);the Medical Innovation Project of Science and Technology Program of Fujian Provincial Health Commission(Grant No.2021CXA006);the Project for High-Level Talent Innovation and Entrepreneurship of Quanzhou(Grant No.2022C016R);the Key Program of Qingyuan Innovation Laboratory(Grant No.00221002).

摘  要:Nanovaccines have gathered significant attention for their potential to elicit tumor-specific immunological responses.Despite notable progress in tumor immunotherapy,nanovaccines still encounter considerable challenges such as low delivery efficiency,limited targeting ability,and suboptimal efficacy.With an aim of addressing these issues,engineering customized nanovaccines through modification or functionalization has emerged as a promising approach.These tailored nanovaccines not only enhance antigen presentation,but also effectively modulate immunosuppression within the tumor microenvironment.Specifically,they are distinguished by their diverse sizes,shapes,charges,structures,and unique physicochemical properties,along with targeting ligands.These features of nanovaccines facilitate lymph node accumulation and activation/regulation of immune cells.This overview of bespoke nanovaccines underscores their potential in both prophylactic and therapeutic applications,offering insights into their future development and role in cancer immunotherapy.

关 键 词:Nanovaccines Customized structure Tailored-ligand Enhanced cancer immunotherapy Prophylactic and therapeutic applications 

分 类 号:R730.51[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象